Cargando…
Immunogenic tumor cell death induced by chemoradiotherapy in a clinical setting
Although it has been shown in murine models that chemoradiotherapy may induce immunogenic tumor cell death, which could trigger T-cell immunity upon the released of high-mobility group box 1 protein (HMGB1), whether this also occurs in clinical settings remains unclear. Here, we discuss tumor-antige...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583908/ https://www.ncbi.nlm.nih.gov/pubmed/23482346 http://dx.doi.org/10.4161/onci.22197 |